Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $1.38 -0.04 (-2.82%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Chemomab Therapeutics Stock Price Performance5 Day Performance-9.80%1 Month Performance-8.61%3 Month Performance+32.69%6 Month Performance+87.70%Year-To-Date Performance+170.59%1 Year Performance+81.67% Receive CMMB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. CMMB Stock Chart for Saturday, November, 2, 2024 CMMB Chart by TradingView Chemomab Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$1.42$1.38-2.82%$1.46$1.3634,801 shs$19.82 million10/31/2024$1.44$1.42-1.39%$1.46$1.4022,776 shs$20.39 million10/30/2024$1.44$1.44$1.48$1.4226,746 shs$20.68 million10/29/2024$1.53$1.44-5.88%$1.60$1.4349,262 shs$15.91 million10/28/2024$1.44$1.53+6.25%$1.53$1.3942,810 shs$16.91 million10/25/2024$1.44$1.44$1.45$1.4049,270 shs$15.91 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$1.55$1.44-7.10%$1.62$1.39316,947 shs$15.91 million10/23/2024$1.58$1.55-1.90%$1.65$1.4936,826 shs$17.13 million10/22/2024$1.63$1.58-3.07%$1.78$1.55162,069 shs$17.46 million10/21/2024$1.57$1.63+3.82%$1.70$1.57139,936 shs$18.01 million10/18/2024$1.28$1.57+22.66%$1.57$1.27241,617 shs$17.35 million10/17/2024$1.26$1.28+1.59%$1.29$1.1758,768 shs$14.14 million10/16/2024$1.31$1.26-3.82%$1.39$1.23118,229 shs$13.92 million10/15/2024$1.20$1.31+9.17%$1.34$1.14365,560 shs$14.48 million10/14/2024$1.13$1.20+6.19%$1.20$1.0964,394 shs$13.26 million10/11/2024$1.20$1.13-5.83%$1.23$1.10129,902 shs$16.23 million10/10/2024$1.29$1.20-6.98%$1.35$1.14334,432 shs$13.26 million10/09/2024$1.36$1.29-4.80%$1.43$1.2886,533 shs$14.25 million10/08/2024$1.43$1.36-5.24%$1.50$1.31156,940 shs$14.97 million10/07/2024$1.51$1.43-5.30%$1.59$1.38185,643 shs$15.80 million10/04/2024$1.51$1.51$1.55$1.4655,692 shs$16.69 million10/03/2024$1.51$1.51$1.58$1.4850,539 shs$16.69 million10/02/2024$1.50$1.51+0.67%$1.54$1.29459,910 shs$16.69 million10/01/2024$1.57$1.50-4.46%$1.67$1.45105,508 shs$16.58 million09/30/2024$1.54$1.57+1.95%$1.78$1.51120,597 shs$17.35 million09/27/2024$1.57$1.54-1.91%$1.62$1.5364,247 shs$22.11 million09/26/2024$1.52$1.57+3.29%$1.65$1.5488,040 shs$22.55 million09/25/2024$1.57$1.52-3.18%$1.62$1.52125,477 shs$21.83 million09/24/2024$1.59$1.57-0.95%$1.74$1.52134,567 shs$17.35 million09/23/2024$1.71$1.59-7.31%$1.74$1.52264,500 shs$17.51 million09/20/2024$1.68$1.71+1.79%$1.76$1.66172,772 shs$18.90 million09/19/2024$1.76$1.68-4.55%$1.79$1.61184,311 shs$18.56 million09/18/2024$1.79$1.76-1.68%$1.85$1.7280,038 shs$19.45 million09/17/2024$1.74$1.79+3.17%$1.82$1.7590,402 shs$19.78 million09/16/2024$1.79$1.74-2.80%$1.89$1.72182,246 shs$19.17 million09/13/2024$2.00$1.78-11.00%$2.00$1.71662,971 shs$25.56 million09/12/2024$2.03$2.00-1.48%$2.23$1.97880,106 shs$22.10 million09/11/2024$2.13$2.03-4.69%$2.23$1.99210,450 shs$22.43 million09/10/2024$2.13$2.13$2.18$2.0865,615 shs$30.59 million09/09/2024$1.90$2.13+12.40%$2.18$1.96108,980 shs$30.59 millionWhy Buffett, Bezos, & Congress Are Piling Into This One Sector (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details09/06/2024$2.29$1.89-17.47%$2.27$1.82555,807 shs$20.88 million09/05/2024$2.42$2.29-5.37%$2.43$2.19316,314 shs$25.30 million09/04/2024$2.46$2.42-1.63%$2.49$2.29277,179 shs$26.74 million09/03/2024$2.02$2.46+21.78%$2.55$2.021.02 million shs$27.18 million09/02/2024$2.02$2.02$2.07$1.87379,600 shs$22.32 million08/30/2024$1.96$2.02+3.06%$2.07$1.87379,303 shs$22.32 million08/29/2024$1.86$1.96+5.38%$1.98$1.81469,129 shs$21.66 million08/28/2024$1.65$1.86+12.73%$1.86$1.65328,550 shs$20.55 million08/27/2024$1.58$1.65+4.43%$1.70$1.51324,956 shs$18.23 million08/26/2024$1.40$1.58+12.86%$1.76$1.42851,026 shs$17.46 million08/23/2024$1.22$1.40+14.75%$1.42$1.181.86 million shs$15.47 million08/22/2024$1.22$1.22$1.22$1.1951,882 shs$13.48 million08/21/2024$1.24$1.22-1.61%$1.24$1.2070,767 shs$13.48 million08/20/2024$1.22$1.24+1.64%$1.30$1.1685,993 shs$13.70 million08/19/2024$1.11$1.22+9.91%$1.30$1.06258,062 shs$13.48 million08/16/2024$1.08$1.11+2.78%$1.11$1.0710,595 shs$12.27 million08/15/2024$1.05$1.08+2.86%$1.15$1.0257,698 shs$11.93 million08/14/2024$1.05$1.05$1.08$1.0218,551 shs$11.60 million08/13/2024$0.95$1.05+10.95%$1.06$0.91127,912 shs$11.60 million08/12/2024$0.93$0.95+1.40%$1.00$0.9134,458 shs$10.46 million08/09/2024$1.01$0.93-7.59%$1.02$0.87135,586 shs$10.31 million08/08/2024$1.00$1.01+1.00%$1.04$0.9945,055 shs$11.16 million08/07/2024$1.04$1.00-3.85%$1.09$0.9952,559 shs$11.05 million08/06/2024$1.03$1.04+0.97%$1.11$1.0165,759 shs$11.49 million08/05/2024$1.04$1.03-0.96%$1.05$0.9368,903 shs$11.38 million08/02/2024$1.16$1.04-10.34%$1.18$0.99117,304 shs$11.49 million08/01/2024$1.17$1.16-0.85%$1.18$1.1649,208 shs$12.82 million Related Companies MURA Stock Chart CDTX Stock Chart RPHM Stock Chart KRON Stock Chart DTIL Stock Chart IMRX Stock Chart CVM Stock Chart BRNS Stock Chart MNPR Stock Chart THTX Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
